Brian Smith, PharmD, explains how direct-to-consumer GLP-1 pathways broaden initial access but endanger long-term patient adherence.
|Articles|March 17, 2003
HSE P&T Portfolio: Humira
Adalimumab(Humira)for use in adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more disease-modifying antirheumatic drugs.
Advertisement
Advertisement
Related to this article
Pharmacists face burnout and financial strain as PBMs take big cuts, prompting urgent calls for reform to protect patient care and community pharmacies.
What pharmacy technicians say would actually make them feel seen on World Pharmacy Technician Day, and the other 364 days of the year.
The analysis is not a head-to-head trial, and the weight loss gap reached statistical significance under 1 of 2 estimands.
A 1.6-million-birth analysis finds that adoption of a 2016 trial's antibiotic protocol climbed sharply in US hospitals, with a drop in infection rates.
New findings suggest semaglutide's benefits may extend well beyond diabetes and weight loss and into airway disease and mood disorders.
First approved for adults in 2022, the therapy is now cleared for adults and pediatric patients weighing 66 lbs or more with symptomatic obstructive hypertrophic cardiomyopathy.
With the inherent value medications provide in the greater health care system, Jennifer Hammons, PharmD, DrPH, argues that rural pharmacies deserve the proper recognition.
Advertisement
Advertisement
Trending on Drug Topics
1
Technicians Aren't Asking for a Party
2
Indirect Comparison Links Tirzepatide to Greater Weight Loss Than Semaglutide
3
Infections Fall With Azithromycin for Unscheduled Cesarean Deliveries
4
Study Links Oral Menopausal Hormone Therapy to Thrombotic Risk
5